Shigeru Sakiyama

4.4k total citations · 1 hit paper
124 papers, 3.8k citations indexed

About

Shigeru Sakiyama is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shigeru Sakiyama has authored 124 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 40 papers in Oncology and 27 papers in Immunology. Recurrent topics in Shigeru Sakiyama's work include Immunotherapy and Immune Responses (20 papers), Cancer-related Molecular Pathways (18 papers) and Virus-based gene therapy research (18 papers). Shigeru Sakiyama is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Cancer-related Molecular Pathways (18 papers) and Virus-based gene therapy research (18 papers). Shigeru Sakiyama collaborates with scholars based in Japan, United States and France. Shigeru Sakiyama's co-authors include Yohko Nakamura, Keizo Takenaga, Masatoshi Tagawa, Toshinori Ozaki, Takaki Hiwasa, Hajime Kageyama, Yoshikazu Nakamura, Ken Tokunaga, Kei Sawada and M Ohkubo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Shigeru Sakiyama

124 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers.

1987 522 citations Shigeru Sakiyama et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shigeru Sakiyama Japan	34	2.4k	935	709	646	634	124	3.8k
D Kufe United States	35	3.1k 1.3×	1.5k 1.6×	716 1.0×	423 0.7×	994 1.6×	78	4.7k
Masayoshi Namba Japan	35	2.8k 1.1×	1.1k 1.2×	533 0.8×	594 0.9×	430 0.7×	186	4.8k
Joseph E. De Larco United States	26	4.1k 1.7×	2.1k 2.3×	959 1.4×	1.1k 1.7×	767 1.2×	39	6.5k
Masaaki Terada Japan	45	3.8k 1.6×	1.6k 1.7×	986 1.4×	824 1.3×	376 0.6×	141	5.9k
Christopher S. Gilbert United Kingdom	15	4.0k 1.7×	1.7k 1.8×	647 0.9×	326 0.5×	887 1.4×	16	5.2k
Hideo Masui United States	30	2.4k 1.0×	2.3k 2.5×	456 0.6×	414 0.6×	406 0.6×	56	5.0k
Masabumi Shibuya Japan	41	4.6k 1.9×	1.7k 1.8×	1.2k 1.7×	455 0.7×	990 1.6×	77	6.6k
Keith Harshman Switzerland	26	3.2k 1.3×	1.9k 2.0×	906 1.3×	497 0.8×	407 0.6×	43	5.0k
L A Donehower United States	24	3.0k 1.3×	1.9k 2.0×	585 0.8×	453 0.7×	360 0.6×	31	4.1k
Elizabeth J. Taparowsky United States	39	3.3k 1.4×	1.4k 1.5×	592 0.8×	658 1.0×	1.7k 2.7×	74	5.6k

Countries citing papers authored by Shigeru Sakiyama

Since Specialization

Citations

This map shows the geographic impact of Shigeru Sakiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Sakiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Sakiyama more than expected).

Fields of papers citing papers by Shigeru Sakiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Sakiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Sakiyama. The network helps show where Shigeru Sakiyama may publish in the future.

Co-authorship network of co-authors of Shigeru Sakiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Sakiyama. A scholar is included among the top collaborators of Shigeru Sakiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Sakiyama. Shigeru Sakiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamura, Yohko, Toshinori Ozaki, Haruhiko Koseki, Akira Nakagawara, & Shigeru Sakiyama. (2003). Accumulation of p27KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. Biochemical and Biophysical Research Communications. 307(1). 206–213. 36 indexed citations

Tada, Yuji, Jiyang O‐Wang, Yuichi Takiguchi, et al.. (2002). Cutting Edge: A Novel Role for Fas Ligand in Facilitating Antigen Acquisition by Dendritic Cells. The Journal of Immunology. 169(5). 2241–2245. 21 indexed citations

Ozaki, Toshinori, Takahiro Nagase, Shingo Ichimiya, et al.. (2000). NFBD1/KIAA0170 Is a Novel Nuclear Transcriptional Transactivator with BRCT Domain. DNA and Cell Biology. 19(8). 475–485. 39 indexed citations

Kawamura, Kiyoko, et al.. (2000). Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity. Cancer Gene Therapy. 7(4). 637–643. 18 indexed citations

Iwadate, Yasuo, Masatoshi Tagawa, Hiroki Namba, et al.. (2000). Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors. Cancer Gene Therapy. 7(9). 1263–1269. 6 indexed citations

Ozaki, Toshinori, M Naka, Norihiko TAKADA, et al.. (1999). Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.. Cancer Research. 59(23). 5902–7. 69 indexed citations

Ichimiya, Shingo, Yoshinori Nimura, Hajime Kageyama, et al.. (1999). p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene. 18(4). 1061–1066. 108 indexed citations

Shimada, Hideaki, Kenji Kadomatsu, T. Muramatsu, et al.. (1999). Frequent Expression of Midkine Gene in Esophageal Cancer Suggests a Potential Usage of Its Promoter for Suicide Gene Therapy. Japanese Journal of Cancer Research. 90(4). 469–475. 34 indexed citations

Nimura, Yoshinori, Motohiro Mihara, Shingo Ichimiya, et al.. (1998). p73, a geme related top53, is not mutated in esophageal carcinomas. International Journal of Cancer. 78(4). 437–440. 73 indexed citations

10.

Kageyama, Hajime, et al.. (1998). DPC4 splice variants in neuroblastoma. Cancer Letters. 122(1-2). 187–193. 12 indexed citations

11.

Takenaga, Keizo, Yohko Nakamura, & Shigeru Sakiyama. (1997). Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene. 14(3). 331–337. 130 indexed citations

12.

Hiwasa, Takaki, et al.. (1996). Synergistic Induction of Anchorage-independent Growth of NIH3T3 Mouse Fibroblasts by Cysteine Proteinase Inhibitors and a Tumor Promoter. Journal of Biological Chemistry. 271(16). 9181–9184. 6 indexed citations

13.

Matsubara, Hisahiro, Keizo Takenaga, Makoto Sugaya, et al.. (1996). Inhibition of peritoneal dissemination of colon carcinoma in syngeneic mice immunized with interleukin-2-producing cells. Cancer Letters. 109(1-2). 171–176. 9 indexed citations

14.

Toyoguchi, Toru, Shinobu Imajoh‐Ohmi, Norio Kato, et al.. (1995). Purification and characterization of recombinant hamster tissue complement C1s. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1250(1). 90–96. 6 indexed citations

15.

Ozaki, Toshinori, Kenji Irie, & Shigeru Sakiyama. (1995). Molecular Cloning and Cell Cycle-Dependent Expression of a Novel Gene That Is Homologous to cdc37. DNA and Cell Biology. 14(12). 1017–1023. 8 indexed citations

16.

Ozaki, Toshinori & Shigeru Sakiyama. (1992). Lamin A gene expression is specifically suppressed in v‐src‐transformed cells. FEBS Letters. 312(2-3). 165–168. 5 indexed citations

17.

Hiwasa, Takaki, Shigeru Sakiyama, Shigeyuki Yokoyama, et al.. (1988). Degradation of epidermal growth factor receptors by cathepsin L‐like protease: Inhibition of the degradation by c‐Ha‐ras gene products. FEBS Letters. 233(2). 367–370. 15 indexed citations

18.

Ohkubo, Michiko, et al.. (1986). Similarity between glyceraldehyde-3-phosphate dehydrogenase and a 37,000-dalton protein which is abundantly expressed in human lung cancers.. PubMed. 77(6). 554–9. 11 indexed citations

19.

Hiwasa, Takaki, Hirota Fujiki, Takashi Sügimura, & Shigeru Sakiyama. (1983). Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates.. PubMed. 43(12 Pt 1). 5951–5. 8 indexed citations

20.

Sakiyama, Shigeru, et al.. (1979). Characterization of messenger RNA for fructose 1,6-bisphosphate aldolase A isozyme of rat ascites hepatoma AH 7974 cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(2 Pt 1). 502–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact